Tranexamic Acid Versus Sublingual Misoprostol in Reducing Blood Loss During Elective CS in High Risk Cases
Status:
Recruiting
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
The Efficacy and safety of Preoperative Intravenous Tranexamic acid versus Sublingual
misoprostol in reducing blood loss during and after Elective Cesarean section among high risk
pregnant cases.